China's self-developed H7N9 avian influenza vaccine into clinical trials
-
Last Update: 2020-06-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Business Association March 4 - National Committee of the Chinese People's Political Consultative Conference (CPPCC) member, Chinese Academy of Engineering academician Li Lanxuan said that China's self-developed H7N9 avian influenza vaccine has been sent to China's pharmaceutical biologics inspection and verification, waiting for the State Food and Drug Administration approval can enter the clinical trial stageLi Lanxuan said that human infection with the H7N9 avian influenza virus vaccine strain is entirely developed by China's own success, the first time to break and change China's flu vaccine strain needs to be provided by foreign countries historyAs for the use of vaccines, Li said that there is no need to blindly panic to inject the vaccine, but the need to contact more poultry people can be vaccinated
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
